Medicare Enrolled

Dr. Emily Rubenstein, D.O

Dermatology · Lincolnshire, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
275 PARKWAY DR, Lincolnshire, IL 60069
8474596400
Registered in NPPES since 2007
NPI: 1598982019 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rubenstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rubenstein? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rubenstein

Dr. Emily Rubenstein is a dermatology specialist in Lincolnshire, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rubenstein performed 789 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Rubenstein received a total of $372,519 from 51 pharmaceutical and/or device companies across 1568 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rubenstein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ 789 Medicare services $372,519 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
789
Medicare services
Bottom 24% in IL for dermatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
228 $5 $27
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
134 $60 $200
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
115 $42 $148
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
110 $91 $279
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
49 $72 $277
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
44 $88 $188
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
38 $62 $254
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
29 $99 $371
Light therapy to destroy precancerous skin growth
This procedure uses light to treat and remove precancerous skin lesions. It is a method for destroying abnormal skin cells before they become cancerous.
21 $80 $334
Topical aminolevulinic acid HCl 20% solution
A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient.
21 $292 $910
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$372,519
Total received (2018-2024)
Avg $53,217/year across 7 years
Top 1% in IL for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
1,568
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$55,213
2023
$81,817
2022
$24,088
2021
$8,337
2020
$30,430
2019
$108,606
2018
$64,029

Payments by company (2024)

Amgen Inc.
$41,198
Dermavant Sciences, Inc.
$7,803
ABBVIE INC.
$2,042
Janssen Biotech, Inc.
$1,730
UCB, Inc.
$263
PFIZER INC.
$255
Novartis Pharmaceuticals Corporation
$254
Lilly USA, LLC
$252
MAYNE PHARMA COMMERCIAL LLC
$196
Incyte Corporation
$195
GENZYME CORPORATION
$189
Galderma Laboratories, L.P.
$168
SUN PHARMACEUTICAL INDUSTRIES INC.
$153
Regeneron Healthcare Solutions, Inc.
$115
E.R. Squibb & Sons, L.L.C.
$104
LEO Pharma Inc.
$77
Ortho Dermatologics, a division of Bausch Health US, LLC
$59
Verrica Pharmaceuticals Inc.
$46
Boehringer Ingelheim Pharmaceuticals, Inc.
$43
Journey Medical Corporation
$31
Arcutis Biotherapeutics, Inc.
$24
Biofrontera Inc.
$15
Top 3 companies account for 92.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$162,676
Celgene Corporation
$146,516
Dermavant Sciences, Inc.
$23,896
Janssen Biotech, Inc.
$6,543
Promius Pharma LLC
$5,157
AbbVie Inc.
$4,361
PFIZER INC.
$3,388
ABBVIE INC.
$3,239
E.R. Squibb & Sons, L.L.C.
$2,588
EPI Health, LLC
$1,736
Galderma Laboratories, L.P.
$1,404
LEO Pharma Inc.
$1,393
Lilly USA, LLC
$1,266
GENZYME CORPORATION
$979
Novartis Pharmaceuticals Corporation
$870
Journey Medical Corporation
$852
Ortho Dermatologics, a division of Bausch Health US, LLC
$815
AbbVie, Inc.
$616
UCB, Inc.
$517
Mayne Pharma Inc.
$506
Incyte Corporation
$446
MAYNE PHARMA COMMERCIAL LLC
$326
Sun Pharmaceutical Industries Inc.
$308
Regeneron Healthcare Solutions, Inc.
$286
Medimetriks Pharmaceuticals, Inc.
$239
SUN PHARMACEUTICAL INDUSTRIES INC.
$225
Puma Biotechnology, Inc.
$194
Dr.Reddy's Laboratories,Inc.
$120
Janssen Scientific Affairs, LLC
$117
Almirall LLC
$108
MAYNE PHARMA INC.
$104
VYNE Pharmaceuticals Inc.
$94
Boehringer Ingelheim Pharmaceuticals, Inc.
$80
Mylan Pharmaceuticals Inc.
$77
Endo Pharmaceuticals Inc.
$68
Arcutis Biotherapeutics, Inc.
$54
Aclaris Therapeutics, Inc.
$53
Verrica Pharmaceuticals Inc.
$46
Encore Dermatology Inc.
$41
SANOFI-AVENTIS U.S. LLC
$25
Sandoz Inc.
$24
DERMIRA, INC.
$22
Sensus Healthcare, Inc.
$21
Mylan Institutional Inc.
$20
STRATA Skin Sciences, Inc.
$18
DUSA Pharmaceuticals, Inc.
$16
Novum Pharma, LLC
$16
PruGen, Inc. Pharmaceuticals
$15
Biofrontera Inc.
$15
Bayer HealthCare Pharmaceuticals Inc.
$13
Exeltis, USA Inc.
$12
Top 3 companies account for 89.4% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Acticlate · Aczone · Alcortin A · BOTOX · Bensal HP · Bimzelx · CIBINQO · CLODERM · COSENTYX · CYLTEZO · Cabtreo · Ceracade · Cimzia · Clindacin ETZ · Clindacin P · Clindamycin Phosphate and Benzoyl Peroxide · Clodan Shampoo · Cloderm Cream · Cordran Tape · DORYX · DUOBRII · DUPIXENT · Dermatological Psoriasis and Vitiligo Treatment · EBGLYSS · EFUDEX · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Ecoza · Enbrel · Exelderm · Finacea · Glatiramer Acetate · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · LEVULAN KERASTICK · LIBTAYO · NERLYNX · Neo-Synalar Cream · Neo-Synalar Cream Kit · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Olux · Otezla · PICATO · QBREXZA · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · STELARA · Sernivo · Sernivo Spray · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TREMFYA · TRIANEX 0.05% · TWYNEO · Targadox · Tremfya · Trianex · ULTRAVATE · VEREGEN · VTAMA · WYNZORA · Winlevi · XELJANZ · XOLAIR · YCANTH · ZILXI · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a dermatology specialist in Lincolnshire?
Compare dermatologists in the Lincolnshire area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists in nearby ZIP areas
262
County median income
$108,917
Nearest hospital to ZIP centroid (approximate)
NORTHWESTERN LAKE FOREST HOSPITAL
4.3 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rubenstein is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rubenstein experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Rubenstein performed 228 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rubenstein receive payments from pharmaceutical companies?
Yes. Dr. Rubenstein received a total of $372,519 from 51 companies across 1,568 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rubenstein's costs compare to other dermatologists in Lincolnshire?
Dr. Rubenstein's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rubenstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →